Global VEGFA Antibody Supply, Demand and Key Producers, 2023-2029
Page: 122
Published Date: 02 Sep 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global VEGFA Antibody market size is expected to reach $ 890.1 million by 2029, rising at a market growth of 11.9% CAGR during the forecast period (2023-2029).
VEGFA is an important cytokine that plays a key role in processes such as angiogenesis, vascular permeability and angiogenesis. It regulates the growth and development of the vascular system by binding to VEGF receptors, and has an important impact on the maintenance of normal physiological status and the development of disease status. The application of VEGFA antibody can be used to detect and analyze the expression level and localization of VEGFA protein in research, especially in the fields of oncology, ophthalmic diseases and cardiovascular diseases. In addition, VEGFA antibody may also be used as a potential strategy for anti-tumor therapy and angiogenesis inhibitory therapy, providing useful information for the treatment and drug development of related diseases.
VEGFA Antibody is an antibody specific for vascular endothelial growth factor A (VEGFA) protein.
This report studies the global VEGFA Antibody production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for VEGFA Antibody, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of VEGFA Antibody that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global VEGFA Antibody total production and demand, 2018-2029, (K Units)
Global VEGFA Antibody total production value, 2018-2029, (USD Million)
Global VEGFA Antibody production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global VEGFA Antibody consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: VEGFA Antibody domestic production, consumption, key domestic manufacturers and share
Global VEGFA Antibody production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global VEGFA Antibody production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global VEGFA Antibody production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global VEGFA Antibody market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sino Biological, Inc., Abcam, Thermo Fisher Scientific (China) Co., Ltd., Bio-Techne, BioLegend, LifeSpan BioSciences, Inc, Elabscience Biotechnology Inc., Boster Biological Technology and Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World VEGFA Antibody market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global VEGFA Antibody Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global VEGFA Antibody Market, Segmentation by Type
Monoclonal Antibody
Polyclonal Antibody
Global VEGFA Antibody Market, Segmentation by Application
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others
Companies Profiled:
Sino Biological, Inc.
Abcam
Thermo Fisher Scientific (China) Co., Ltd.
Bio-Techne
BioLegend
LifeSpan BioSciences, Inc
Elabscience Biotechnology Inc.
Boster Biological Technology
Merck
Wuhan Fine Biotech Co., Ltd.
ProSci Incorporated
Abbexa
Miltenyi Biotec
Arigo Biolaboratories Corp.
Assay Genie
Key Questions Answered
1. How big is the global VEGFA Antibody market?
2. What is the demand of the global VEGFA Antibody market?
3. What is the year over year growth of the global VEGFA Antibody market?
4. What is the production and production value of the global VEGFA Antibody market?
5. Who are the key producers in the global VEGFA Antibody market?
Table of Contents
1 Supply Summary
1.1 VEGFA Antibody Introduction
1.2 World VEGFA Antibody Supply & Forecast
1.2.1 World VEGFA Antibody Production Value (2018 & 2022 & 2029)
1.2.2 World VEGFA Antibody Production (2018-2029)
1.2.3 World VEGFA Antibody Pricing Trends (2018-2029)
1.3 World VEGFA Antibody Production by Region (Based on Production Site)
1.3.1 World VEGFA Antibody Production Value by Region (2018-2029)
1.3.2 World VEGFA Antibody Production by Region (2018-2029)
1.3.3 World VEGFA Antibody Average Price by Region (2018-2029)
1.3.4 North America VEGFA Antibody Production (2018-2029)
1.3.5 Europe VEGFA Antibody Production (2018-2029)
1.3.6 China VEGFA Antibody Production (2018-2029)
1.3.7 Japan VEGFA Antibody Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 VEGFA Antibody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 VEGFA Antibody Major Market Trends
2.1 World VEGFA Antibody Demand (2018-2029)
2.2 World VEGFA Antibody Consumption by Region
2.2.1 World VEGFA Antibody Consumption by Region (2018-2023)
2.2.2 World VEGFA Antibody Consumption Forecast by Region (2024-2029)
2.3 United States VEGFA Antibody Consumption (2018-2029)
2.4 China VEGFA Antibody Consumption (2018-2029)
2.5 Europe VEGFA Antibody Consumption (2018-2029)
2.6 Japan VEGFA Antibody Consumption (2018-2029)
2.7 South Korea VEGFA Antibody Consumption (2018-2029)
2.8 ASEAN VEGFA Antibody Consumption (2018-2029)
2.9 India VEGFA Antibody Consumption (2018-2029)
3.1 World VEGFA Antibody Production Value by Manufacturer (2018-2023)
3.2 World VEGFA Antibody Production by Manufacturer (2018-2023)
3.3 World VEGFA Antibody Average Price by Manufacturer (2018-2023)
3.4 VEGFA Antibody Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global VEGFA Antibody Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for VEGFA Antibody in 2022
3.5.3 Global Concentration Ratios (CR8) for VEGFA Antibody in 2022
3.6 VEGFA Antibody Market: Overall Company Footprint Analysis
3.6.1 VEGFA Antibody Market: Region Footprint
3.6.2 VEGFA Antibody Market: Company Product Type Footprint
3.6.3 VEGFA Antibody Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: VEGFA Antibody Production Value Comparison
4.1.1 United States VS China: VEGFA Antibody Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: VEGFA Antibody Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: VEGFA Antibody Production Comparison
4.2.1 United States VS China: VEGFA Antibody Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: VEGFA Antibody Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: VEGFA Antibody Consumption Comparison
4.3.1 United States VS China: VEGFA Antibody Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: VEGFA Antibody Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based VEGFA Antibody Manufacturers and Market Share, 2018-2023
4.4.1 United States Based VEGFA Antibody Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers VEGFA Antibody Production Value (2018-2023)
4.4.3 United States Based Manufacturers VEGFA Antibody Production (2018-2023)
4.5 China Based VEGFA Antibody Manufacturers and Market Share
4.5.1 China Based VEGFA Antibody Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers VEGFA Antibody Production Value (2018-2023)
4.5.3 China Based Manufacturers VEGFA Antibody Production (2018-2023)
4.6 Rest of World Based VEGFA Antibody Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based VEGFA Antibody Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers VEGFA Antibody Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers VEGFA Antibody Production (2018-2023)
5.1 World VEGFA Antibody Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibody
5.2.2 Polyclonal Antibody
5.3 Market Segment by Type
5.3.1 World VEGFA Antibody Production by Type (2018-2029)
5.3.2 World VEGFA Antibody Production Value by Type (2018-2029)
5.3.3 World VEGFA Antibody Average Price by Type (2018-2029)
6.1 World VEGFA Antibody Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Flow Cytometry
6.2.2 ELISA
6.2.3 Western Blot
6.2.4 Immunoprecipitation
6.2.5 Immunofluorescence
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World VEGFA Antibody Production by Application (2018-2029)
6.3.2 World VEGFA Antibody Production Value by Application (2018-2029)
6.3.3 World VEGFA Antibody Average Price by Application (2018-2029)
7.1 Sino Biological, Inc.
7.1.1 Sino Biological, Inc. Details
7.1.2 Sino Biological, Inc. Major Business
7.1.3 Sino Biological, Inc. VEGFA Antibody Product and Services
7.1.4 Sino Biological, Inc. VEGFA Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sino Biological, Inc. Recent Developments/Updates
7.1.6 Sino Biological, Inc. Competitive Strengths & Weaknesses
7.2 Abcam
7.2.1 Abcam Details
7.2.2 Abcam Major Business
7.2.3 Abcam VEGFA Antibody Product and Services
7.2.4 Abcam VEGFA Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Abcam Recent Developments/Updates
7.2.6 Abcam Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific (China) Co., Ltd.
7.3.1 Thermo Fisher Scientific (China) Co., Ltd. Details
7.3.2 Thermo Fisher Scientific (China) Co., Ltd. Major Business
7.3.3 Thermo Fisher Scientific (China) Co., Ltd. VEGFA Antibody Product and Services
7.3.4 Thermo Fisher Scientific (China) Co., Ltd. VEGFA Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
7.3.6 Thermo Fisher Scientific (China) Co., Ltd. Competitive Strengths & Weaknesses
7.4 Bio-Techne
7.4.1 Bio-Techne Details
7.4.2 Bio-Techne Major Business
7.4.3 Bio-Techne VEGFA Antibody Product and Services
7.4.4 Bio-Techne VEGFA Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Bio-Techne Recent Developments/Updates
7.4.6 Bio-Techne Competitive Strengths & Weaknesses
7.5 BioLegend
7.5.1 BioLegend Details
7.5.2 BioLegend Major Business
7.5.3 BioLegend VEGFA Antibody Product and Services
7.5.4 BioLegend VEGFA Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 BioLegend Recent Developments/Updates
7.5.6 BioLegend Competitive Strengths & Weaknesses
7.6 LifeSpan BioSciences, Inc
7.6.1 LifeSpan BioSciences, Inc Details
7.6.2 LifeSpan BioSciences, Inc Major Business
7.6.3 LifeSpan BioSciences, Inc VEGFA Antibody Product and Services
7.6.4 LifeSpan BioSciences, Inc VEGFA Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 LifeSpan BioSciences, Inc Recent Developments/Updates
7.6.6 LifeSpan BioSciences, Inc Competitive Strengths & Weaknesses
7.7 Elabscience Biotechnology Inc.
7.7.1 Elabscience Biotechnology Inc. Details
7.7.2 Elabscience Biotechnology Inc. Major Business
7.7.3 Elabscience Biotechnology Inc. VEGFA Antibody Product and Services
7.7.4 Elabscience Biotechnology Inc. VEGFA Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Elabscience Biotechnology Inc. Recent Developments/Updates
7.7.6 Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
7.8 Boster Biological Technology
7.8.1 Boster Biological Technology Details
7.8.2 Boster Biological Technology Major Business
7.8.3 Boster Biological Technology VEGFA Antibody Product and Services
7.8.4 Boster Biological Technology VEGFA Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Boster Biological Technology Recent Developments/Updates
7.8.6 Boster Biological Technology Competitive Strengths & Weaknesses
7.9 Merck
7.9.1 Merck Details
7.9.2 Merck Major Business
7.9.3 Merck VEGFA Antibody Product and Services
7.9.4 Merck VEGFA Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Merck Recent Developments/Updates
7.9.6 Merck Competitive Strengths & Weaknesses
7.10 Wuhan Fine Biotech Co., Ltd.
7.10.1 Wuhan Fine Biotech Co., Ltd. Details
7.10.2 Wuhan Fine Biotech Co., Ltd. Major Business
7.10.3 Wuhan Fine Biotech Co., Ltd. VEGFA Antibody Product and Services
7.10.4 Wuhan Fine Biotech Co., Ltd. VEGFA Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
7.10.6 Wuhan Fine Biotech Co., Ltd. Competitive Strengths & Weaknesses
7.11 ProSci Incorporated
7.11.1 ProSci Incorporated Details
7.11.2 ProSci Incorporated Major Business
7.11.3 ProSci Incorporated VEGFA Antibody Product and Services
7.11.4 ProSci Incorporated VEGFA Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 ProSci Incorporated Recent Developments/Updates
7.11.6 ProSci Incorporated Competitive Strengths & Weaknesses
7.12 Abbexa
7.12.1 Abbexa Details
7.12.2 Abbexa Major Business
7.12.3 Abbexa VEGFA Antibody Product and Services
7.12.4 Abbexa VEGFA Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Abbexa Recent Developments/Updates
7.12.6 Abbexa Competitive Strengths & Weaknesses
7.13 Miltenyi Biotec
7.13.1 Miltenyi Biotec Details
7.13.2 Miltenyi Biotec Major Business
7.13.3 Miltenyi Biotec VEGFA Antibody Product and Services
7.13.4 Miltenyi Biotec VEGFA Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Miltenyi Biotec Recent Developments/Updates
7.13.6 Miltenyi Biotec Competitive Strengths & Weaknesses
7.14 Arigo Biolaboratories Corp.
7.14.1 Arigo Biolaboratories Corp. Details
7.14.2 Arigo Biolaboratories Corp. Major Business
7.14.3 Arigo Biolaboratories Corp. VEGFA Antibody Product and Services
7.14.4 Arigo Biolaboratories Corp. VEGFA Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Arigo Biolaboratories Corp. Recent Developments/Updates
7.14.6 Arigo Biolaboratories Corp. Competitive Strengths & Weaknesses
7.15 Assay Genie
7.15.1 Assay Genie Details
7.15.2 Assay Genie Major Business
7.15.3 Assay Genie VEGFA Antibody Product and Services
7.15.4 Assay Genie VEGFA Antibody Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Assay Genie Recent Developments/Updates
7.15.6 Assay Genie Competitive Strengths & Weaknesses
8.1 VEGFA Antibody Industry Chain
8.2 VEGFA Antibody Upstream Analysis
8.2.1 VEGFA Antibody Core Raw Materials
8.2.2 Main Manufacturers of VEGFA Antibody Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 VEGFA Antibody Production Mode
8.6 VEGFA Antibody Procurement Model
8.7 VEGFA Antibody Industry Sales Model and Sales Channels
8.7.1 VEGFA Antibody Sales Model
8.7.2 VEGFA Antibody Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World VEGFA Antibody Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World VEGFA Antibody Production Value by Region (2018-2023) & (USD Million)
Table 3. World VEGFA Antibody Production Value by Region (2024-2029) & (USD Million)
Table 4. World VEGFA Antibody Production Value Market Share by Region (2018-2023)
Table 5. World VEGFA Antibody Production Value Market Share by Region (2024-2029)
Table 6. World VEGFA Antibody Production by Region (2018-2023) & (K Units)
Table 7. World VEGFA Antibody Production by Region (2024-2029) & (K Units)
Table 8. World VEGFA Antibody Production Market Share by Region (2018-2023)
Table 9. World VEGFA Antibody Production Market Share by Region (2024-2029)
Table 10. World VEGFA Antibody Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World VEGFA Antibody Average Price by Region (2024-2029) & (US$/Unit)
Table 12. VEGFA Antibody Major Market Trends
Table 13. World VEGFA Antibody Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World VEGFA Antibody Consumption by Region (2018-2023) & (K Units)
Table 15. World VEGFA Antibody Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World VEGFA Antibody Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key VEGFA Antibody Producers in 2022
Table 18. World VEGFA Antibody Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key VEGFA Antibody Producers in 2022
Table 20. World VEGFA Antibody Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global VEGFA Antibody Company Evaluation Quadrant
Table 22. World VEGFA Antibody Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and VEGFA Antibody Production Site of Key Manufacturer
Table 24. VEGFA Antibody Market: Company Product Type Footprint
Table 25. VEGFA Antibody Market: Company Product Application Footprint
Table 26. VEGFA Antibody Competitive Factors
Table 27. VEGFA Antibody New Entrant and Capacity Expansion Plans
Table 28. VEGFA Antibody Mergers & Acquisitions Activity
Table 29. United States VS China VEGFA Antibody Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China VEGFA Antibody Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China VEGFA Antibody Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based VEGFA Antibody Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers VEGFA Antibody Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers VEGFA Antibody Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers VEGFA Antibody Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers VEGFA Antibody Production Market Share (2018-2023)
Table 37. China Based VEGFA Antibody Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers VEGFA Antibody Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers VEGFA Antibody Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers VEGFA Antibody Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers VEGFA Antibody Production Market Share (2018-2023)
Table 42. Rest of World Based VEGFA Antibody Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers VEGFA Antibody Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers VEGFA Antibody Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers VEGFA Antibody Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers VEGFA Antibody Production Market Share (2018-2023)
Table 47. World VEGFA Antibody Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World VEGFA Antibody Production by Type (2018-2023) & (K Units)
Table 49. World VEGFA Antibody Production by Type (2024-2029) & (K Units)
Table 50. World VEGFA Antibody Production Value by Type (2018-2023) & (USD Million)
Table 51. World VEGFA Antibody Production Value by Type (2024-2029) & (USD Million)
Table 52. World VEGFA Antibody Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World VEGFA Antibody Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World VEGFA Antibody Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World VEGFA Antibody Production by Application (2018-2023) & (K Units)
Table 56. World VEGFA Antibody Production by Application (2024-2029) & (K Units)
Table 57. World VEGFA Antibody Production Value by Application (2018-2023) & (USD Million)
Table 58. World VEGFA Antibody Production Value by Application (2024-2029) & (USD Million)
Table 59. World VEGFA Antibody Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World VEGFA Antibody Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Sino Biological, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Sino Biological, Inc. Major Business
Table 63. Sino Biological, Inc. VEGFA Antibody Product and Services
Table 64. Sino Biological, Inc. VEGFA Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Sino Biological, Inc. Recent Developments/Updates
Table 66. Sino Biological, Inc. Competitive Strengths & Weaknesses
Table 67. Abcam Basic Information, Manufacturing Base and Competitors
Table 68. Abcam Major Business
Table 69. Abcam VEGFA Antibody Product and Services
Table 70. Abcam VEGFA Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Abcam Recent Developments/Updates
Table 72. Abcam Competitive Strengths & Weaknesses
Table 73. Thermo Fisher Scientific (China) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Thermo Fisher Scientific (China) Co., Ltd. Major Business
Table 75. Thermo Fisher Scientific (China) Co., Ltd. VEGFA Antibody Product and Services
Table 76. Thermo Fisher Scientific (China) Co., Ltd. VEGFA Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
Table 78. Thermo Fisher Scientific (China) Co., Ltd. Competitive Strengths & Weaknesses
Table 79. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 80. Bio-Techne Major Business
Table 81. Bio-Techne VEGFA Antibody Product and Services
Table 82. Bio-Techne VEGFA Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Bio-Techne Recent Developments/Updates
Table 84. Bio-Techne Competitive Strengths & Weaknesses
Table 85. BioLegend Basic Information, Manufacturing Base and Competitors
Table 86. BioLegend Major Business
Table 87. BioLegend VEGFA Antibody Product and Services
Table 88. BioLegend VEGFA Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. BioLegend Recent Developments/Updates
Table 90. BioLegend Competitive Strengths & Weaknesses
Table 91. LifeSpan BioSciences, Inc Basic Information, Manufacturing Base and Competitors
Table 92. LifeSpan BioSciences, Inc Major Business
Table 93. LifeSpan BioSciences, Inc VEGFA Antibody Product and Services
Table 94. LifeSpan BioSciences, Inc VEGFA Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. LifeSpan BioSciences, Inc Recent Developments/Updates
Table 96. LifeSpan BioSciences, Inc Competitive Strengths & Weaknesses
Table 97. Elabscience Biotechnology Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Elabscience Biotechnology Inc. Major Business
Table 99. Elabscience Biotechnology Inc. VEGFA Antibody Product and Services
Table 100. Elabscience Biotechnology Inc. VEGFA Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Elabscience Biotechnology Inc. Recent Developments/Updates
Table 102. Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
Table 103. Boster Biological Technology Basic Information, Manufacturing Base and Competitors
Table 104. Boster Biological Technology Major Business
Table 105. Boster Biological Technology VEGFA Antibody Product and Services
Table 106. Boster Biological Technology VEGFA Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Boster Biological Technology Recent Developments/Updates
Table 108. Boster Biological Technology Competitive Strengths & Weaknesses
Table 109. Merck Basic Information, Manufacturing Base and Competitors
Table 110. Merck Major Business
Table 111. Merck VEGFA Antibody Product and Services
Table 112. Merck VEGFA Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Merck Recent Developments/Updates
Table 114. Merck Competitive Strengths & Weaknesses
Table 115. Wuhan Fine Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Wuhan Fine Biotech Co., Ltd. Major Business
Table 117. Wuhan Fine Biotech Co., Ltd. VEGFA Antibody Product and Services
Table 118. Wuhan Fine Biotech Co., Ltd. VEGFA Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
Table 120. Wuhan Fine Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 121. ProSci Incorporated Basic Information, Manufacturing Base and Competitors
Table 122. ProSci Incorporated Major Business
Table 123. ProSci Incorporated VEGFA Antibody Product and Services
Table 124. ProSci Incorporated VEGFA Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. ProSci Incorporated Recent Developments/Updates
Table 126. ProSci Incorporated Competitive Strengths & Weaknesses
Table 127. Abbexa Basic Information, Manufacturing Base and Competitors
Table 128. Abbexa Major Business
Table 129. Abbexa VEGFA Antibody Product and Services
Table 130. Abbexa VEGFA Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Abbexa Recent Developments/Updates
Table 132. Abbexa Competitive Strengths & Weaknesses
Table 133. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
Table 134. Miltenyi Biotec Major Business
Table 135. Miltenyi Biotec VEGFA Antibody Product and Services
Table 136. Miltenyi Biotec VEGFA Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Miltenyi Biotec Recent Developments/Updates
Table 138. Miltenyi Biotec Competitive Strengths & Weaknesses
Table 139. Arigo Biolaboratories Corp. Basic Information, Manufacturing Base and Competitors
Table 140. Arigo Biolaboratories Corp. Major Business
Table 141. Arigo Biolaboratories Corp. VEGFA Antibody Product and Services
Table 142. Arigo Biolaboratories Corp. VEGFA Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Arigo Biolaboratories Corp. Recent Developments/Updates
Table 144. Assay Genie Basic Information, Manufacturing Base and Competitors
Table 145. Assay Genie Major Business
Table 146. Assay Genie VEGFA Antibody Product and Services
Table 147. Assay Genie VEGFA Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of VEGFA Antibody Upstream (Raw Materials)
Table 149. VEGFA Antibody Typical Customers
Table 150. VEGFA Antibody Typical Distributors
List of Figure
Figure 1. VEGFA Antibody Picture
Figure 2. World VEGFA Antibody Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World VEGFA Antibody Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World VEGFA Antibody Production (2018-2029) & (K Units)
Figure 5. World VEGFA Antibody Average Price (2018-2029) & (US$/Unit)
Figure 6. World VEGFA Antibody Production Value Market Share by Region (2018-2029)
Figure 7. World VEGFA Antibody Production Market Share by Region (2018-2029)
Figure 8. North America VEGFA Antibody Production (2018-2029) & (K Units)
Figure 9. Europe VEGFA Antibody Production (2018-2029) & (K Units)
Figure 10. China VEGFA Antibody Production (2018-2029) & (K Units)
Figure 11. Japan VEGFA Antibody Production (2018-2029) & (K Units)
Figure 12. VEGFA Antibody Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World VEGFA Antibody Consumption (2018-2029) & (K Units)
Figure 15. World VEGFA Antibody Consumption Market Share by Region (2018-2029)
Figure 16. United States VEGFA Antibody Consumption (2018-2029) & (K Units)
Figure 17. China VEGFA Antibody Consumption (2018-2029) & (K Units)
Figure 18. Europe VEGFA Antibody Consumption (2018-2029) & (K Units)
Figure 19. Japan VEGFA Antibody Consumption (2018-2029) & (K Units)
Figure 20. South Korea VEGFA Antibody Consumption (2018-2029) & (K Units)
Figure 21. ASEAN VEGFA Antibody Consumption (2018-2029) & (K Units)
Figure 22. India VEGFA Antibody Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of VEGFA Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for VEGFA Antibody Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for VEGFA Antibody Markets in 2022
Figure 26. United States VS China: VEGFA Antibody Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: VEGFA Antibody Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: VEGFA Antibody Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers VEGFA Antibody Production Market Share 2022
Figure 30. China Based Manufacturers VEGFA Antibody Production Market Share 2022
Figure 31. Rest of World Based Manufacturers VEGFA Antibody Production Market Share 2022
Figure 32. World VEGFA Antibody Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World VEGFA Antibody Production Value Market Share by Type in 2022
Figure 34. Monoclonal Antibody
Figure 35. Polyclonal Antibody
Figure 36. World VEGFA Antibody Production Market Share by Type (2018-2029)
Figure 37. World VEGFA Antibody Production Value Market Share by Type (2018-2029)
Figure 38. World VEGFA Antibody Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World VEGFA Antibody Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World VEGFA Antibody Production Value Market Share by Application in 2022
Figure 41. Flow Cytometry
Figure 42. ELISA
Figure 43. Western Blot
Figure 44. Immunoprecipitation
Figure 45. Immunofluorescence
Figure 46. Others
Figure 47. World VEGFA Antibody Production Market Share by Application (2018-2029)
Figure 48. World VEGFA Antibody Production Value Market Share by Application (2018-2029)
Figure 49. World VEGFA Antibody Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. VEGFA Antibody Industry Chain
Figure 51. VEGFA Antibody Procurement Model
Figure 52. VEGFA Antibody Sales Model
Figure 53. VEGFA Antibody Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Sino Biological, Inc. Abcam Thermo Fisher Scientific (China) Co., Ltd. Bio-Techne BioLegend LifeSpan BioSciences, Inc Elabscience Biotechnology Inc. Boster Biological Technology Merck Wuhan Fine Biotech Co., Ltd. ProSci Incorporated Abbexa Miltenyi Biotec Arigo Biolaboratories Corp. Assay Genie
Related Reports
02 Sep 2023
Pharma & Healthcare
Product Tags
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
